Home Topics Oncology

Oncology

Latest
Coronavirus particles, illustration
Oncology

Cancer Patients May Have Poor Responses to COVID-19 Vaccines

Eye cancer, eye disease, 3d illustration
Oncology

Immunocore’s KIMMTRAK for Unresectable or Metastatic Uveal Melanoma Gets FDA Approval

Stop it
Oncology

FDA Puts Five Trials of Gilead Cancer Candidate Magrolimab on Partial...

Tumor - Cancer cells reproduction
Oncology

Enzymes That Remove Lactic Acid Marks May Increase Understanding of Cancer...

Prostate cancer, illustration
Oncology

Optimal High-Risk Prostate Cancer ADT Duration May Be Radiotherapy-Dependent

Gut bacteria , gut flora, microbiome. Bacteria inside the small intestine, concept, representation. 3D illustration.
Oncology

Gut Microbiome May Affect Immunotherapy Effect

Brain cancer, conceptual artwork
Oncology

Novel Strategy Can Help Sensitize Glioma Cells To Radiotherapy

Different family types seamless pattern
Oncology

U.K.’s Our Future Health Aims to Transform Disease Prevention, Detection, Treatment

Destruction of leukaemia cell
Oncology

Blood Cancer Gene Defect Could Be Treated by Existing PARP Inhibitors

Senior woman having a mammography scan at hospital
Oncology

Breast Cancer AI Could Help Determine Need for Biopsy

Load more

Featured

Cancer Patients May Have Poor Responses to COVID-19 Vaccines

Cancer Patients May Have Poor Responses to COVID-19 Vaccines

Immunocore’s KIMMTRAK for Unresectable or Metastatic Uveal Melanoma Gets FDA Approval

Immunocore’s KIMMTRAK for Unresectable or Metastatic Uveal Melanoma Gets FDA Approval

Enzymes That Remove Lactic Acid Marks May Increase Understanding of Cancer Therapies

Enzymes That Remove Lactic Acid Marks May Increase Understanding of Cancer Therapies

Optimal High-Risk Prostate Cancer ADT Duration May Be Radiotherapy-Dependent

Optimal High-Risk Prostate Cancer ADT Duration May Be Radiotherapy-Dependent

New Products

View All
Load more
Copyright © 2022 Genetic Engineering & Biotechnology News. All Rights Reserved.